Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

PURPOSE: Patients with advanced pancreas cancer present with disease that is poorly responsive to conventional therapies. Preclinical and early clinical evidence has supported targeting the epidermal growth factor receptor (EGFR) signaling pathway in patients with pancreas cancer. This trial was con...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Philip, Philip A., Benedetti, Jacqueline, Corless, Christopher L., Wong, Ralph, O'Reilly, Eileen M., Flynn, Patrick J., Rowland, Kendrith M., Atkins, James N., Mirtsching, Barry C., Rivkin, Saul E., Khorana, Alok A., Goldman, Bryan, Fenoglio-Preiser, Cecilia M., Abbruzzese, James L., Blanke, Charles D.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society of Clinical Oncology 2010
الموضوعات:
Original Reports
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC2917315/
https://ncbi.nlm.nih.gov/pubmed/20606093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.7550
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة